Clearance Summary
PERM. IMPLANT. ENDOCARDIAL PAC. LEAD received FDA 510(k) clearance under submission number K770195, sponsored by Daig Corp.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Cardiovascular review panel. The statutory decision date of record is 1977-02-07.
- Submission: K770195
- Applicant / Sponsor: Daig Corp.
- Clearance pathway: Traditional
- Review panel: Cardiovascular
- Device class: Class III
- Regulation citation: 21 CFR 870.3680
- Decision date: 1977-02-07
Classification & Regulation
This clearance is catalogued under FDA product code DTB and 21 CFR 870.3680, within the Cardiovascular review panel as a Class III device.